A Phase 1, Dose-Escalation/ Dose-Expansion Study Evaluating the Safety, pharmacokinetics, and Pharmacodynamic Effects of Orally Administered CB-5083 in Subjects with Lymphoid Hematological Malignancies - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 1, Dose-Escalation/ Dose-Expansion Study Evaluating the Safety, pharmacokinetics, and Pharmacodynamic Effects of Orally Administered CB-5083 in Subjects with Lymphoid Hematological Malignancies

Type of Cancer
Hematological Malignancies
Locations
Bethesda
Sponsor
Protocol Number
CLC-102
Cancer Diagnosis
To Learn More Call
201-510-0910